Citryll
Citryll is a Targeting Neutrophil Extracellular Traps
Citryll has raised €119M across 3 funding rounds from 9 investors, most recently a Series B round in Dec 2024. Based in Oss, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€119M
€118,500,000
Funding rounds
3
Investors
9
distinct backers
Active since
2019-07
latest 2024-12
Funding by year
EUR raised per yearCitryll — funding by year — interactive chart.
Data table
| Citryll — funding by year | |
|---|---|
| 2019 | €15M |
| 2020 | €19M |
| 2024 | €85M |
Signals
High confidenceRaise-next likelihood66
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 7y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-10 | Series B | €85M | BioGeneration Ventures,BOM,Citryll’s founders,Curie Capital,Forbion,Johnson & Johnson+3 more | View deal → |
| 2020-02-07 | Other | €19M | BioGeneration Ventures,Seventure Partners | View deal → |
| 2019-07-01 | Series A | €15M | — | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData